4th Oncological Sciences Symposium – New Horizons in Oncology Prostate Cancer

Invited Spekers
Emmanuel S. Antonarakis, M.B.B.Ch - Johns Hopkins Medicine
Richard Hindley, M:D: - NorthHampshire Hospitals

09:30 – 10:00 OPENING CEREMONY AND GREETING REMARKS

10:00 – 12:00 DIAGNOSIS AND STAGING

Chair: Haluk Özen M.D. / Hacettepe University

Cemil Uygur M.D. / Anadolu Medical Center

10:00 – 10:20 PSA and new markers; can biopsy selection be changed

Can Öbek M.D. / Acıbadem Hospital

10:20 – 10:40 Genetics in prostate cancer

Uğur Özbek M.D. / Istanbul University Faculty of Medicine

10:40 – 11:00 MRI of the prostate: present and future

Barış Bakır M.D. / Istanbul University Faculty of Medicine

11:00 – 11:20 PSMA PET in prostate cancer, an update

Levent Kabasakal M.D. / Cerrahpaşa University Faculty of Medicine

11:20 – 11-40 Pathology of prostate cancer

Hüseyin Baloğlu M.D. / Anadolu Medical Center

11:40 – 12:00 Newly diagnosed localized disease. To treat or not to treat

Saadettin Eskiçorapçı M.D. / Acıbadem Hospital

12:00 – 13:00 Lunch

13:00 – 15:20 TREATMENT OF PROSTATE CANCER - I

Chair: Veli Yalçın M.D. / Acıbadem Hospital

13:00 – 13:20 Surgical treatment of localized prostate cancer; traditional or robotics

Ömer Burak Argun M.D. / Acıbadem Hospital

13:20 – 13:40 Primary radiation treatment of localized prostate cancer

Hale Başak Çağlar M.D. / Anadolu Medical Center

13:40 – 14:00 Management of High Risk / locally advanced disease

Sinan Sözen M.D. / Gazi University Faculty of Medicine

14:00 – 14:20 The role of radiation in postsurgery and PSA recurrences

Şefik İğdem M.D. / Istanbul Bilim University Faculty of Medicine

14:20 – 14:40 Management of nodal recurrences after primary treatment

Haluk Akpınar M.D. / Florence Nightingale Hospitals

14: 40 – 15:00 Management of oligometastatic prostate cancer

Levent Türkeri M.D. / Acıbadem Hospital

15:00 – 15: 20 Focal treatment options

Richard Hindley M.D. / North Hampshire Hospital

15:20 – 15:40 Coffee break

15:40 – 18:00 TREATMENT OF PROSTATE CANCER - II

Chair: Necdet Üskent M.D. / Anadolu Medical Center

Haluk Onat M.D. / Istanbul Oncology Hospital

15:40 – 16:00 The role of chemotherapy in metastatic prostate cancer

Sevil Bavbek M.D. / Koç University Hospital

16:00 – 16:20 The role of radiation therapy in metastatic prostate cancer

Hale Başak Çağlar M.D. / Anadolu Medical Center

16:20 – 16:40 Targeted radionuclide therapy of prostate cancer

Levent Kabasakal M.D. / Cerrahpaşa University Faculty of Medicine

16:40 – 17:00 Emerging Immunotherapeutic options in CRPC

Necdet Üskent M.D. / Anadolu Medical Center

17:00 – 17:20 Sequencing treatment options in Adjuvant and Metastatic setting

Emmanuel Antonarakis M.D. / Johns Hopkins Medicine

17:20 – 18:00 New AR-targeted agents in CRPC

Emmanuel Antonarakis M.D. / Johns Hopkins Medicine

18:00 – 18:30 Case discussion

Levent Türkeri M.D. / Acıbadem Hospital

Levent Kabasakal M.D. / Cerrahpaşa University Faculty of Medicine

Emmanuel Antonarakis M.D. / Johns Hopkins Medicine

Sevil Bavbek M.D. / Koç University Hospital

Hale Başak Çağlar M.D. / Anadolu Medical Center

Şefik İğdem M.D. / Istanbul Bilim University Faculty of Medicine

Sinan Sözen M.D. / Gazi University Faculty of Medicine

Sadettin Eskiçorapçı M.D. / Acıbadem Hospital

Richard Hindley M.D. / North Hampshire Hospital

Haluk Akpınar M.D. / Florence Nightingale Hospitals

Can Öbek M.D. / Acıbadem Hospital

Ömer Burak Argun M.D. / Acıbadem Hospital

18:30 Closing Remarks